TREATMENT OF HER3 MUTANT CANCER BY ADMINISTRATION OF ANTI-HER3 ANTIBODY-DRUG CONJUGATE

• 收藏
• 分享

专利权人:

Daiichi Sankyo Company; Limited

发明人:

申请号：

EP19863647.4

公开号：

EP3854418A1

申请日:

2019.09.19

申请国别(地区):

EP

年份:

2021

代理人:

摘要：

A therapeutic agent for HER3-mutated cancer containing an anti-HER3 antibody-drug conjugate as an active ingredient and/or a method of treatment for cancer, the method including administering an anti-HER3 antibody-drug conjugate to a subject determined to have HER3-mutated cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/